Dofus

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dofus

Quick Facts

Property Description
Active Ingredient Lactobacillus acidophilus (INN)
Type/Origin Naturally occurring live microorganism (Biologic)
Pharmacological Class Probiotic, Antidiarrheal
Common Forms Oral capsule, tablet, powder
Availability Over-the-counter (OTC)

Dofus Defined: Classification and Active Ingredient

Dofus is a proprietary preparation classified as a probiotic whose single core component is the active ingredient, Lactobacillus acidophilus (INN). This preparation falls under the high-level category of supplements used to manage digestive upset and is composed of live microorganisms intended to supplement the body's native bacterial population. As a strain of beneficial bacteria, Lactobacillus acidophilus is utilized to support the bacterial environment in the intestine. This supports the preparation's primary role in promoting a healthy microbial environment in the gut.

The product's identity as a probiotic signifies that it introduces beneficial bacterial strains to the system. L. acidophilus is a strain of acid-producing bacteria that, when supplied in the oral preparation, is designed to support the intestinal flora. This approach is a standard method for restoring balance after microbial disruption.

Composition, Origin, and Available Forms

The active substance in Dofus is Lactobacillus acidophilus, a naturally occurring biologic that is cultured, harvested, and prepared as viable, stabilized cultures. This ingredient is a bacterial species naturally found in the human digestive system and oral cavity. This specific strain is recognized as a viable option for managing flora disruptions and plays an established role in restoring the gut’s microbial balance.

Dofus is generally available as an over-the-counter (OTC) product and is designed for oral administration. It is supplied in various dosage forms, commonly including the oral capsule, oral tablet, or oral powder, where the active ingredient is protected by excipients to ensure the viability and stability of the live microorganisms until consumption.

General Purpose: Sustaining Intestinal Flora Balance

The general purpose of Dofus is to restore and maintain the normal balance of intestinal bacteria within the gastrointestinal tract. By introducing a significant, bioavailable population of beneficial L. acidophilus through the oral route, the preparation helps to reinforce the gut's natural microbial defenses. A typical use scenario involves its application following a course of antibiotics when the native flora is temporarily depleted. This function ensures the digestive system is equipped to maintain a stable environment, which is conducive to overall healthy stomach and intestines.

What side effects are possible with Dofus?

Possible Side Effects and Safety Information

Official regulatory information regarding Dofus focuses primarily on the potential for allergic reactions and other serious, systemic adverse effects, for which the incidence is generally classified as not known in the available documents.

Serious and Clinically Significant Adverse Reactions

Adverse reactions that may be indicative of a serious hypersensitivity response, such as anaphylaxis, require immediate attention. These reactions can involve several body systems and include symptoms like:

  • Dermatologic/Systemic: Hives, itching, rash, or significant swelling of the eyelids, face, lips, or tongue.
  • Respiratory: Trouble breathing, coughing, or tightness in the chest.
  • Cardiovascular/General: Fast heartbeat, dizziness, difficulty with swallowing, or unusual tiredness or weakness.

Population-Specific Safety Considerations

Regulatory safety materials highlight specific gaps in population data:

  • Pediatric and Geriatric Use: The relationship between age and the effects of Dofus has not been formally established in adequate studies for either pediatric or geriatric patient populations.
  • Breastfeeding: There are no adequate and well-controlled studies to determine the risk to an infant when Dofus is used by a person who is breastfeeding.

Safety Restrictions and Monitoring

The primary safety limitation involves the potential for allergic reactions to Dofus or any of its ingredients. Patients are typically advised to be monitored for signs of hypersensitivity. Potential for interactions with other prescription or nonprescription medicines is also noted as a key safety consideration. The overall safety profile frames the understanding of risk around potential allergic events, while also acknowledging the limited data concerning vulnerable patient groups.

Overdose and Emergency Response

Official Overdose Profile and Toxic Risk

Official regulatory documentation classifies the risk of acute, dose-dependent toxicity following ingestion of excessive quantities of Dofus (Lactobacillus acidophilus) as negligible. Regulatory sources do not define a specific acute toxic overdose syndrome or list severe systemic outcomes, such as cardiovascular or neurological depression, resulting solely from high-dose ingestion.

  • Documented Manifestations: In cases of over-ingestion, clinical manifestations documented are limited to general, non-serious gastrointestinal effects, such as flatulence and bloating.
  • Antidote and Treatment: No specific antidote is known or documented in official labeling. Management is officially described as primarily symptomatic and supportive treatment; procedural steps like gastric lavage are not mandated by regulators.

When to Seek Urgent Medical Help

The official labeling explicitly dictates when emergency medical help must be sought. Immediate medical attention is required not for dose-dependent poisoning, but if any signs of a severe adverse reaction or systemic hypersensitivity are experienced.

  • Urgent Action Trigger: Contact emergency services immediately if the patient exhibits symptoms of a severe reaction, including difficulty breathing or swelling of the face, tongue, or throat.
  • General Guidance: Regulatory authorities advise contacting a local Poison Control Center for guidance if a significantly excessive amount is ingested.

Therapeutic Uses of Dofus

Quick Facts

  • Indicated for: Supporting the microbial balance within the gastrointestinal system.
  • Therapeutic utility: May contribute to the management of occasional diarrhea, including in circumstances related to antibiotic use.
  • Additional potential use: Under clinical investigation for helping to maintain the health of the urinary and vaginal tracts.

What Dofus treats: main uses and benefits

Dofus is a product containing Lactobacillus acidophilus, a naturally occurring bacteria that may support the maintenance of a favorable balance of microorganisms in the digestive tract. This formulation is primarily studied and employed to support the management of certain gastrointestinal concerns.

Its therapeutic utility is associated with addressing occasional diarrhea, particularly when there are disruptions to the normal intestinal flora, such as those that may occur during a course of antibiotics. Using Dofus may help alleviate the duration or severity of this type of diarrhea. Individuals may note improvements in their overall digestive comfort while taking this product.

In addition to its gastrointestinal applications, Dofus is also utilized for its potential role in supporting the bacterial balance of the urinary tract and vaginal tract. These applications are areas of ongoing research and may be relevant for women seeking to maintain a healthy microbial environment in these areas.

Regulatory References

  1. https://medlineplus.gov/druginfo/meds/a601048.html

Eligibility and Restrictions for Use

Who Can and Cannot Use Dofus? (Official Regulatory Information)

Official labeling for Dofus (Lactobacillus acidophilus) strictly defines population eligibility based on age, physiological status, and underlying health conditions. The preparation is generally allowed for use by healthy adults and children aged three years and older under standard Over-The-Counter (OTC) conditions.

Absolute Non-Eligibility

Use is contraindicated for individuals with a known hypersensitivity to any product ingredient and must be avoided in premature infants. Individuals who are immunocompromised (e.g., undergoing chemotherapy or with HIV/AIDS) or who have conditions like GI wall perforation are generally not recommended to use this medicine.

Restricted and Conditional Use

Use requires medical supervision for pregnant women due to the lack of adequate, controlled studies. Use is not recommended for infants and children under three years of age unless directed by a physician. Caution is also advised for patients with systemic issues like damaged heart valves or liver scarring (cirrhosis). Regulatory documents indicate that use is not established for geriatric patients as specific data is unavailable.

What should I know about interactions with other medicines?

The official regulatory documents define the interaction profile of Dofus, whose active ingredient is Lactobacillus acidophilus, around its nature as a live organism. Co-administration with certain antimicrobials, specifically antibiotics and antifungals, may lead to a reduction in the viability of the live microbial content. This effect diminishes the intended biological exposure and subsequent activity of Dofus.

To mitigate this viability-compromising interaction, regulatory guidance dictates a mandatory administration-timing rule. Dofus products should be administered with a separation period of at least 2 hours from the dose of any systemic antibiotic. Regarding pharmacokinetic interactions, Dofus is not formally documented as participating in the major CYP450 enzyme systems or interacting with key drug transport proteins like P-gp, meaning no classic metabolic or transporter-mediated interactions are officially listed.

A separate population-specific interaction note exists concerning patients with a weakened immune system. Due to the introduction of live microorganisms, use of Dofus in immunosuppressed patients (resulting from disease or concurrent medication) is associated with an increased, documented risk of systemic infection, such as bacteremia or fungemia. No other combinations are strictly classified as contraindicated solely due to interaction risk. The documented constraints center on timing separation with antimicrobials and heightened caution in the immunosuppressed population.

Mechanism of Action

How Dofus Works — Mechanism of Action

The mechanism of action for Dofus (Lactobacillus acidophilus) is rooted in a multi-faceted biological strategy aimed at modulating intestinal physiological function. Its effects are categorized into three core mechanistic domains that influence the GI tract.


Microbiome Competitive Regulation

This domain describes how L. acidophilus physically and metabolically influences the intestinal environment. By engaging in competitive exclusion for epithelial adhesion sites and producing lactic acid to lower the local pH, the organism restricts the growth of non-native bacteria. This process influences the composition of the gut flora.


Intestinal Barrier Reinforcement

This mechanism involves the interaction of L. acidophilus with the host’s intestinal epithelial cells. This contact modulates the function of Tight Junction proteins, which are the molecular components that seal the spaces between cells. The resulting fortification of the barrier reduces the intestine's permeability, influencing systemic GI physiological status.


Local Immunological Modulation

L. acidophilus and its metabolites directly interact with local immune cells within the gut tissue, influencing cellular signaling pathways like NF-,kappaB. This activity modulates the production of local mediators, resulting in a dampened profile of local immune signaling within the intestinal mucosa.

Dosage and Administration Information

The administration of Dofus, a preparation containing Lactobacillus acidophilus, follows usage patterns typical of oral probiotic supplements. It is administered through the oral route, with common dosage forms including the capsule, tablet, and powder. The daily dosage is specified in Colony Forming Units (CFU) and is product-specific, generally ranging from 1 billion CFU up to 60 billion CFU for adult regimens.

Frequency patterns vary based on the intended duration of use, with regimens spanning both short-term, acute application and long-term maintenance, which can extend for up to six months. The preparation is typically taken once daily for ongoing microbial support or may be scheduled for divided use multiple times per day for intensive courses. Standard parameters for intake involve consuming Dofus with or without food. Administration of dosage forms with protective features, such as enteric-coated capsules, requires that the product be swallowed whole without being crushed or opened. This is a procedural constraint necessary for the delivery of the live component. Furthermore, guidelines for pediatric patients three years of age and older often specify a distinct, lower daily CFU range, such as up to 30 billion CFUs, reinforcing the need for specific, age-based procedural adherence.

Recent Clinical Evidence

Research evidence / Overview of studies for Dofus

The research on Dofus, which contains Lactobacillus acidophilus, has primarily focused on studies exploring the balance of microorganisms in the digestive tract and other body systems. This overview summarizes the structure of the existing scientific evidence, including the types of studies that have been conducted and the known limitations in the data.


Evidence for use in Antibiotic-Associated Diarrhea (AAD) Prevention

Research examined how Dofus was studied for its potential role in managing the disruption of the gut's microbial balance that can occur during antibiotic use. These studies typically involved Randomized Controlled Trials (RCTs) and subsequent meta-analyses in adults and children. The primary outcomes describing episodic or acute changes that were measured included the incidence of AAD and the duration of diarrheal episodes.

Studies report how symptoms evolved in the observed populations, and findings were mixed when focusing specifically on the single L. acidophilus strain. Evidence quality varies across studies, and the certainty of findings for this single strain is not as consistently established as for the probiotic category as a whole. Long-term effects are not fully established.


Evidence for use in Acute Diarrhea in Children

Dofus was evaluated in research exploring short-term symptom changes in infants and children experiencing acute, short-lived diarrhea. These studies monitored outcomes describing episodic or acute changes, primarily looking at the duration of diarrhea and the frequency of bowel movements. Some studies reported how symptoms evolved in the observed populations, while other, well-controlled trials described no measurable difference compared to control groups. Research highlights that the findings were mixed.

Evidence is limited for the single L. acidophilus strain in this context due to this conflicting data. Furthermore, sample sizes were modest in many trials, which contributes to the uncertainty surrounding the strength of this evidence.


Research on Microbial Balance in the Vaginal Tract

Dofus was studied for its potential role in conditions characterized by functional imbalance of the microbial community in the vaginal tract. Clinical trials and observational settings were applied in studies examining patient-reported experiences in women of reproductive age. Studies generally reported patterns of Lactobacillus colonization when administered. However, the consistency of findings for the single L. acidophilus strain was observed to be lower compared to the results for the genus as a whole. The certainty remains low because comparative evidence is lacking.


Study Gaps and Uncertainty in the Research Record

The research evidence for Dofus provides context regarding what has been studied and what is still uncertain. Key limitations include the fact that the sample sizes were modest in many single-strain trials, and the results apply only to the populations studied. There is a documented lack of large-scale, high-certainty data specifically supporting consistent findings for the single L. acidophilus strain across all studied applications. Research in the areas described is ongoing, which means that the full evidence landscape is still developing.

Key Studies & References

  1. MedlinePlus: Lactobacillus acidophilus
  2. Lactobacillus acidophilus: Uses, Side Effects, Interactions, Dosage, and Warning

Frequently Asked Questions (FAQ)

Common questions about Dofus (FAQ)

Q: How long does it typically take for Dofus to start working?

Official information indicates that for some short-term uses, such as managing acute changes in the gut's microbial balance, the product is sometimes not recommended for self-medication for more than two days without further consultation. This suggests that the expected effect for some uses may begin to occur within a short time frame, though individual responses can vary. Referencing the instructions provides context for the duration of the specific regimen described.


Q: Does Dofus interact with alcohol?

Regulatory guidance primarily focuses on the necessary timing separation from antibiotic medications. While direct contraindications with alcohol are generally not documented, consumption of alcohol is described as potentially affecting the viability of the live microorganisms in the product. This effect is considered to potentially impact the viability and intended biological activity of the preparation.


Q: Can Dofus cause drowsiness?

The official safety profiles do not list common side effects like drowsiness. However, symptoms such as severe dizziness and unusual weakness are listed in the official documents because they may be associated with a serious allergic reaction, which is noted as requiring attention.


Q: Is it normal to feel slightly dizzy after starting Dofus?

Official safety documents list dizziness as a symptom of a serious allergic reaction. The documents do not describe mild or temporary dizziness as a common or non-serious side effect that is typically expected. Any occurrence of symptoms, including dizziness, is noted for informational purposes.


Q: What types of side effects are generally most common with Dofus?

According to official safety information, common, non-serious side effects that usually do not require medical attention may include an increase in gas (flatus) and bloating. These symptoms typically occur at the start of treatment and often subside as the body adjusts to the preparation.


Q: Can people with liver problems use Dofus?

Official documentation advises caution for individuals with specific pre-existing conditions, such as advanced liver scarring (cirrhosis). Official documents describe that for individuals with underlying health conditions, including specific liver issues, consultation with a healthcare provider is generally necessary before use.


Q: Can Dofus be used by people with kidney problems?

Regulatory documents list specific restrictions for conditions like severe immune compromise and specific heart issues. Kidney problems are not listed as a specific contraindication or a special precaution in the official safety information.


Q: What is the description of Dofus's use in the official drug information?

In official regulatory and health information, the active ingredient in Dofus is described as a preparation used to assist in reestablishing the normal balance of intestinal flora. It is commonly used for managing uncomplicated diarrhea, especially when it is related to changes in the intestinal flora, such as after using antibiotics.


Q: What kind of research has been done on Dofus?

Research has been structured around exploring the potential role of the active ingredient in managing disruptions of the gut's microbial balance. Studies have examined its application for antibiotic-associated diarrhea, acute diarrhea in children, and functional imbalances in the vaginal tract.


Q: Does taking Dofus require a special diet?

Official instructions state that the product can be consumed with or without food. There are no specific regulatory requirements for a restrictive or special diet documented for general use. However, some preparations may contain milk or lactose, which is a consideration for those with known hypersensitivity to those ingredients.


Q: Is Dofus a painkiller?

The official classification identifies Dofus as a Probiotic, not as an analgesic or painkiller. Its defined purpose is to restore and help maintain the balance of intestinal bacteria.


Q: If I am taking Dofus, can I still drive a car?

Official documents do not contain specific warnings regarding operating machinery or driving. The side effect profile does not typically include effects that impair cognitive or motor skills, except for the rare symptom of severe dizziness in the context of a hypersensitivity reaction.


Q: Are there any common foods to avoid while on Dofus?

The main administration instruction is that the product can be taken with or without food. The only food-related constraint noted in some product information is a warning against use in individuals with a known hypersensitivity to milk or lactose products, as these are sometimes present in the final preparation.


Q: What happens if Dofus is stopped suddenly?

Official documents provide instruction for treatment duration, which may range from short-term to long-term regimens. However, there are no descriptions of any withdrawal symptoms or rebound effects upon sudden cessation of use, suggesting the product does not require a tapering process.


Q: Does Dofus affect blood pressure?

Official safety information and interaction profiles do not list changes to blood pressure as a known or expected side effect or interaction associated with the use of this preparation.


Q: What is the chance of having a serious side effect from Dofus?

Regulatory safety information states that the incidence of serious systemic adverse effects, such as a severe allergic reaction (anaphylaxis), is generally classified as not known in the available documents. The risk of serious infection is specifically documented as heightened only for individuals who are immunosuppressed.


Q: Do studies suggest Dofus works better for some patient groups than others?

The evidence summary highlights that findings were mixed across the studied populations, which included adults, children, and women of reproductive age. Study results apply only to the populations examined, and some well-controlled trials described no measurable difference compared to control groups.


Q: What is the difference between Dofus and a standard over-the-counter medicine?

Dofus is classified as a probiotic, which means its active component is a live microorganism intended to supplement the body's native bacteria. This live, biologic nature fundamentally distinguishes it from standard chemical or synthetic over-the-counter medicines.


Q: Is Dofus available over the counter in any country?

Official documentation identifies Dofus as an Over-the-counter (OTC) product, which confirms its availability status without requiring a prescription in the region of the primary regulatory labeling.


Q: What happens if I miss a dose of Dofus?

Official administration instructions advise that if a dose is missed, it should be used as soon as it is remembered. However, if it is near the time of the next scheduled dose, the missed dose should be skipped, and the regular schedule maintained without taking a double dose.


Q: Is Dofus safe to use long-term?

Regulatory research summaries indicate that while some regimens extend for up to six months, the long-term effects are not fully established in all contexts. There is a documented lack of large-scale, high-certainty data specifically supporting consistent long-term findings.


Q: Is Dofus a medication that treats symptoms or the underlying cause?

The mechanism of action is described as rooted in modulating intestinal function by influencing the composition of the gut flora, reinforcing the intestinal barrier, and modulating local immune signaling. This description points to effects on the underlying microbial and physiological environment of the gut.

How should Dofus be stored and disposed of?

How to Store and Dispose of Dofus?

Because Dofus contains live microorganisms, official labeling dictates strict storage conditions to maintain the product's viability and potency.

Storage and Handling

  • Temperature: Store at the labeled temperature, which may be Controlled Room Temperature or refrigerated (2^circ to 8 C) depending on the formulation.
  • Protection: The product must be stored in its tightly closed container to protect from moisture and light and must NOT FREEZE.
  • Child Safety: Keep Dofus out of the sight and reach of children to prevent accidental ingestion.

Disposal Requirements

Discard any unused or expired product and its container in accordance with local regulations. Regulatory agencies generally advise against flushing medicine down the toilet; use authorized drug take-back programs or follow specific household disposal instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dofus found in:

A-Z Index: